Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Langsted

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Preventive Cardiology|March 5, 2025
Challenges in Achieving LDL Cholesterol Targets and Novel Approaches to Lipid LoweringWaqas A Malick, Daein Choi, Anne Langsted, et al.
Atherosclerosis|August 21, 2025
Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort studyMie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, et al.
European Journal of Preventive Cardiology|March 4, 2025
Diabetes and elevated plasma glucose in heart valve calcification and disease: the Copenhagen General Population StudyMorten Kaltoft, Shoaib Afzal, Børge G Nordestgaard, et al.
Journal of the American College of Cardiology|November 17, 2022
Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular DiseaseBerit Storgaard Hedegaard, Christian Sørensen Bork, Morten Kaltoft, et al.
Plos One|December 23, 2025
Correction: Comparison of frailty instruments for predicting mortality and prolon ged hospitalization in acute coronary syndrome patientsAnne Langsted, Jocelyne Benatar, Andrew Kerr, et al.
Plos One|February 7, 2025
Comparison of frailty instruments for predicting mortality and prolon ged hospitalization in acute coronary syndrome patientsAnne Langsted, Jocelyne Benatar, Andrew Kerr, et al.
Journal of Clinical Lipidology|January 30, 2026
VLDL cholesterol and ASCVD risk: A population-based studyMie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, et al.
Atherosclerosis|December 14, 2021
Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population StudyMorten Kaltoft, Per E Sigvardsen, Shoaib Afzal, et al.
European Heart Journal|June 23, 2018
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention settingRutger Verbeek, Renate M Hoogeveen, Anne Langsted, et al.
International Journal of Cardiology|February 16, 2025
Prevalence of obesity among adult patients with congenital heart disease: A population-based studyMathilde S K Vangedal, Jani Thuraiaiyah, Troels H Joergensen, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Preventive Cardiology|March 5, 2025
Challenges in Achieving LDL Cholesterol Targets and Novel Approaches to Lipid LoweringWaqas A Malick, Daein Choi, Anne Langsted, et al.
Atherosclerosis|August 21, 2025
Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort studyMie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, et al.
European Journal of Preventive Cardiology|March 4, 2025
Diabetes and elevated plasma glucose in heart valve calcification and disease: the Copenhagen General Population StudyMorten Kaltoft, Shoaib Afzal, Børge G Nordestgaard, et al.
Journal of the American College of Cardiology|November 17, 2022
Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular DiseaseBerit Storgaard Hedegaard, Christian Sørensen Bork, Morten Kaltoft, et al.
Plos One|December 23, 2025
Correction: Comparison of frailty instruments for predicting mortality and prolon ged hospitalization in acute coronary syndrome patientsAnne Langsted, Jocelyne Benatar, Andrew Kerr, et al.
Plos One|February 7, 2025
Comparison of frailty instruments for predicting mortality and prolon ged hospitalization in acute coronary syndrome patientsAnne Langsted, Jocelyne Benatar, Andrew Kerr, et al.
Journal of Clinical Lipidology|January 30, 2026
VLDL cholesterol and ASCVD risk: A population-based studyMie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, et al.
Atherosclerosis|December 14, 2021
Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population StudyMorten Kaltoft, Per E Sigvardsen, Shoaib Afzal, et al.
European Heart Journal|June 23, 2018
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention settingRutger Verbeek, Renate M Hoogeveen, Anne Langsted, et al.
International Journal of Cardiology|February 16, 2025
Prevalence of obesity among adult patients with congenital heart disease: A population-based studyMathilde S K Vangedal, Jani Thuraiaiyah, Troels H Joergensen, et al.
Pageof 8